CLOS
AGN

Compagnie Lombard Odier SCmA’s Allergan plc AGN Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-600
Closed -$3K – 579
2019
Q3 		$3K Buy
+600
New +$97.8K ﹤0.01% 501
2018
Q1 		– Sell
-12,600
Closed -$110K – 678
2017
Q4 		$110K Buy
+12,600
New +$2.26M ﹤0.01% 466

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Compagnie Lombard Odier SCmA's AGN Position: Q2 2020 in Review

Compagnie Lombard Odier SCmA sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 169,191 shares — an estimated $30M sold.

Compagnie Lombard Odier SCmA first reported a position in AGN in Q1 2016 and held it in 17 quarters. The position peaked at $105M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Compagnie Lombard Odier SCmA reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 169,191 Allergan plc shares in Q2 2020, an estimated $30M.
  • Compagnie Lombard Odier SCmA first reported a position in Allergan plc in Q1 2016 and held it in 17 quarters.
  • Compagnie Lombard Odier SCmA's Allergan plc position peaked at $105M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2020, filed 14 Aug 2020.